Britain's largest breast cancer charity says it can save lives if more women get a drug that can prevent it.
Reports say that the cheaper drug, Bisphosphonates, can reduce the number of breast cancer deaths in the UK. The cost of bisphosphonate per day is about 43 pence for the treatment of osteoporosis. A 2015 study showed that the drug also reduced the number of breast cancer patients within 10 years after menopause, and their relapse rate dropped from 8.8% to 6.6% after treatment.
The UK's largest Breast Cancer Now is a merger of the Anti-British Breast Cancer Charity and the UK Breast Cancer Campaign, which claims to be providing breast cancer treatment for all menopausal women. Women in Scotland and Wales are more likely to get this medicine because most cancer centers in Scotland and Wales have access to it. Although not all patients can benefit from it, it estimates that if all breast cancer patients in the UK receive the drug, it will reduce 1,180 deaths per year, equivalent to one-tenth of all deaths. In addition, the Breast Cancer Clinical Panel of the British Breast Cancer Organization and the National Health Service of the United Kingdom also supported the use of bisphosphonates.
The charity said in a report that after the development of the past 25 years, the lack of funds has led to the "stagnation of breast cancer progress." According to the information disclosure request form of the UK Clinical Commissioning Group, only 42 (20.2%) of the 208 clinical commissioning groups in China often provide these drugs for postmenopausal patients. There are also 13 clinical commissioning groups (6.2%) who said they are about to invest in this action. Due to the loss of a large number of mammography radiologists, the acceptance rate for screening is reduced (by 21% in 2020 and 32% in 2025). The crisis is approaching looming.
“Although we have seen tangible progress in recent decades, these data highlight the UK National Health Service’s reaching a worrying bottleneck in breast cancer treatment.†Morgan Stanley )Say. “Funding pressure is now affecting the UK's cancer strategy, but the red tape is still preventing major breakthroughs in research from benefiting the UK National Health Service.†“With the increasing incidence, the government and the UK National Health Service do not have Addressing the issues of disease prevention and secondary breast cancer – we need to see urgent action.â€
However, the British National Health Service did not accept the agency’s new findings. A spokesman for the National Health Service said: "The report is fundamentally flawed. The current survival rate of breast cancer is at an all-time high. In addition to upgrading modern radiotherapy equipment , it ensures faster access to the most promising new In addition to cancer drugs, we also plan to invest 200 million pounds in the next two years to support modern medical treatment."
The National Institute of Health and Human Health has studied the 2015 study, but believes that this is still not enough to determine the benefits of postmenopausal women. They believe that high-risk cancer women may be more effective and point out the side effects of bisphosphonates. Currently, they are upgrading the instructions for bisphosphonates.
Source: World Wide Web
Realistic 3D textured and ribbed tunnel stimulation on the dick with each thrusting, brings you the marvelous sexual experience.
Made of soft and high quality body-safe TPE material, flexible, skin like feeling.
The shape of vagina is copy of real women, it will make you feel haveing sex with real girl.
Male Masturbator,Pocket Pussy Sleeve,Flexible Tpe Pocket Pussy,Flexible Tpe Male Masturbator
Dongguan Chenkuang Biological Technology Co., Ltd , https://www.cksexdoll.com